Luigi Cavanna was born in Piacenza (Italy) in 1953. He gained his Medical degree from the University of Pavia (Italy) in 1978 summa cum laude, after completing a fellowship in hematology/oncology; he subsequently specialized in haematology (1981), in internal medicine (1986), in medical oncology (1989), and in gastroenterology (1993) at the University of Pavia. From 1981 to 1994, he worked as an Assistant and then as a Senior Attending Internist at the Hospital of Piacenza. In 1994, he became the Director of the 1th Internal Medical Division and Onco-Hematology Hospital of Piacenza. In 2000, he was appointed Director of the Hematology-Oncology Program of the city of Piacenza (Italy). He visited in 1985 Institut de Recherches sur les Leucémies et les Maladies du Sang, Hospital S. Louis, Paris, in 1991 the Institutet Karolinska, Stockholm, in 1997 the Comprehensive Cancer Center of New-Haven and the Hospice of the new-Haven Cancer Center, and in 1998 the MD Anderson Cancer Center of Houston. He has been and is still teacher at the Specialization School in Oncology of the Faculty of Medicine and Surgery of the University of Pavia and Parma. In 2001, he became Coordinator of Palliative Care Program of Azienda Sanitaria of Piacenza. In 2004, he was appointed Director of Department of Oncology and Hematology Hospital of Piacenza. This Department, in September 2008, obtained the title of Center of excellence of ESMO, designated center of integrated oncology and palliative care. The main objects of his research activity are the diagnosis, management, and treatment of patients with malignant lymphoma, hepatocellular carcinoma, gastrointestinal cancer, breast cancer, and lung cancer. He conducted several GCP clinical studies as Principal Investigator. The study conducted: gastric cancer, breast cancer, lung cancer, colon-rectal cancer, malignant lymphoma, and cancer pain. He is a Member of several scientific associations, among which the American Society of Clinical Oncology (ASCO), the European Society Medical Oncology (ESMO), the European Hematology Association (EHA), the European Group for Blood and Marrow Transplantation (EBMT), the Associazione Italiana Oncologia Medica (AIOM). His clinical and scientific activity is documented by hundred of papers mainly published in international journals and presented at national and international congresses. He is author of 140 scientific international publications and of 5 scientific books.